Medicines Control Council approves Tarceva® in South Africa for treatment of non-small cell lung cancer

Authors

  • Editorial Office

Abstract

Thousands of South African lung cancer patients could now live longer and with improved quality of life if they receive Tarceva

 

® (erlonitib), a novel alternative to traditional chemotherapy, recently approved by the Medicines Control Council (MCC).

Downloads

Issue

Section

Press Releases